SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-18-006923
Filing Date
2018-10-09
Accepted
2018-10-09 17:21:24
Documents
4
Period of Report
2018-10-09

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_100918.htm 6-K 9499
2 EXHIBIT 99.1 exh_991.htm EX-99.1 194582
3 EXHIBIT 99.2 exh_992.htm EX-99.2 9937
4 GRAPHIC osler.jpg GRAPHIC 5195
  Complete submission text file 0001171843-18-006923.txt   222308
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-35776 | Film No.: 181114394
SIC: 2834 Pharmaceutical Preparations